Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients

Table 2

Comparison of clinical, serological, virological, and histological baseline data among SVRs and non-SVRs. SVR: sustained virological response; BMI: body mass index; Anti-HBc: antibody against Hepatitis B core antigen (*), 𝑃<.05.

	SVRs	non-SVRs
	𝑛=115	𝑛=53
Age (years)	37.69±11.04	50.28±13.35 (*)
Gender (male/female)	73/42	34/19
BMI	24.51±3.29	25.29±3.17
Genotype 1 (n, %)	42 (36.5%)	38 (71.7%) (*)
Genotype non-1 (n, %)	73 (63.5%)	15 (28.3%) (*)
Grade (0–18)	5.41±1.77	5.75±2.02
Stage (0–6)	1.98±1.12	3.33±1.63 (*)
Anti-HBc (+/−)	30/85	21/32